Skip to content

Gm2 Gangliosidosis Juvenile C0268276

Published: July 22, 2026Updated: August 20, 2026

A rare inherited disorder where fats accumulate in brain cells, causing progressive movement problems, seizures, and cognitive decline. Onset occurs in childhood. Care focuses on symptom management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizure‑like episodes

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Progressive loss of ambulation

(neurologic)

Dystonia

(neurologic)

Severe developmental regression

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticonvulsant therapy

Seizure control through appropriate anticonvulsant medications selected based on seizure type and individual patient response with regular reassessment.

medication
2

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication

Additional treatment options

Gastrostomy tube placement

Surgical placement of feeding tube when dysphagia and aspiration risk become significant concerns to maintain adequate nutrition and hydration safely.

procedure

Physical and occupational therapy

Therapeutic exercises and interventions to preserve functional abilities, manage spasticity, and support independence in daily activities.

physical_therapy

Respiratory function monitoring

Regular assessment of pulmonary function and early intervention for respiratory complications including infection prevention and secretion management.

monitoring

Psychosocial support for families

Counseling and support services for parents and caregivers to address the emotional and practical challenges of caring for a child with severe neurological disease.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Gm2 Gangliosidosis Juvenile C0268276?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Gm2 Gangliosidosis Juvenile C0268276. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy